LAVA Therapeutics NV (LAVA Therapeutics NV) Total Liabilities : $50.53 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Total Liabilities?

LAVA Therapeutics NV's Total Liabilities for the quarter that ended in Dec. 2023 was $50.53 Mil.

LAVA Therapeutics NV's quarterly Total Liabilities declined from Jun. 2023 ($58.65 Mil) to Sep. 2023 ($56.42 Mil) and declined from Sep. 2023 ($56.42 Mil) to Dec. 2023 ($50.53 Mil).

LAVA Therapeutics NV's annual Total Liabilities increased from Dec. 2021 ($20.88 Mil) to Dec. 2022 ($57.39 Mil) but then declined from Dec. 2022 ($57.39 Mil) to Dec. 2023 ($50.53 Mil).

LAVA Therapeutics NV Total Liabilities Historical Data

The historical data trend for LAVA Therapeutics NV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Total Liabilities Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

2.95

12.87

20.88

57.39

50.53

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial												57.39	60.01	58.65	56.42	50.53

LAVA Therapeutics NV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LAVA Therapeutics NV's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.941	+	(0.591	+	-7.105427357601E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	35	+	0)
	=	50.53

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	101.71	-	51.178
	=	50.53

LAVA Therapeutics NV's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.941	+	(0.591	+	-7.105427357601E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	35	+	0)
	=	50.53

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	101.71	-	51.178
	=	50.53

LAVA Therapeutics NV Total Liabilities Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.